Sandwich vs. Mixed Bone Augmentation for Implant Placement

October 16, 2026 updated by: University of California, San Francisco

Comparison of Dental Implant Placement With Simultaneous Sandwich Bone Augmentation vs. Mixed Bone Augmentation: a Randomized Controlled Pilot Study

This study is being done to see which of two common grafting techniques-mixing two different grafting materials or layering two grafting materials-works better to augment bone volume next to participant's dental implant(s). The investigators want to know which technique results in better bone augmentation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • San Francisco, California, United States, 94143
        • Periodontology Clinic, UCSF School of Dentistry
        • Contact:
          • Guo-Hao Lin, DDS, MS
          • Phone Number: 415-476-1731

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Minimum dentition of 20 permanent teeth
  • Single edentulous site at maxillary premolar, canine, lateral incisor, or central incisor
  • Adjacent teeth present with sufficient clearance for an implant crown
  • Ridge width between 4 mm and 7 mm at the edentulous site

Exclusion Criteria:

  • Systemic criteria:

    • Current heavy smokers (>10 cigarettes per day) or heavy smokers who quitted less than 1 year
    • Pregnancy or lactating mothers
    • Diseases of the immune system or any medical condition that may influence the treatment outcome (for examples uncontrolled diabetes (HbA1c >7), uncontrolled cardiovascular disease, neurologic or psychiatric disorders, systemic infections, history of radiation therapy in the head and neck area, current use of oral bisphosphonates for >3 years or history of IV bisphosphonates use, current alcoholism or drug abuse, etc.)
  • Intraoral criteria:

    • Acute infection at/or adjacent to the edentulous site (e.g., sinus tract, swelling, etc.)
    • Observable gingival changes due to use of medications such as calcium antagonists, anticonvulsives, immunosuppressants, anti-inflammatory medications, etc.)
    • Generalized uncontrolled dental diseases, e.g. caries, periodontal diseases, etc.
    • Uncontrolled periodontal disease
    • Poor oral hygiene (>20% plaque score)
  • CBCT criteria:

    • More than 7 mm of alveolar ridge with at the edentulous site present on CBCT scans

  • Intraoperative criteria:

    • An implant without primary stability >35N

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sandwich bone augmentation

The exposed threads on the buccal side of the implant will be grafted with three distinct layers of grafting materials.

Active Comparator: Mixed bone augmentation

The exposed threads on the buccal side of the implant will be grafted with three grafting materials mixed together.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dental Implant's Horizontal Bone Gain (mm) Measured by Cone-Beam Computed Tomography (CBCT)
Time Frame: 1 year after crown delivery

Horizontal bone gain will be measured in millimeters (mm) by comparing CBCT images obtained at baseline and follow-up. Measurements will be performed using computer-based imaging software to quantify changes in horizontal alveolar ridge width at the treated site.

1 year after crown delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant Survival Rate Assessed by Clinical Examination
Time Frame: 1 year after crown delivery

Implant survival will be assessed by the treating provider through clinical examination at the specified follow-up time point. An implant will be considered surviving if it remains present and in function at the time of evaluation.

1 year after crown delivery
Pink Esthetic Score (PES) of Dental Implant Site Assessed by a Blinded Examiner
Time Frame: 1 year after crown delivery

Peri-implant esthetic outcomes will be evaluated by a blinded examiner using the Pink Esthetic Score (PES). The PES will be determined according to the predefined components of the scoring system, with higher scores indicating a more favorable peri-implant soft-tissue esthetic outcome.

1 year after crown delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Guo-Hao Lin, DDS, MS, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

September 14, 2026

First Submitted That Met QC Criteria

September 18, 2026

First Posted (Actual)

September 22, 2026

Study Record Updates

Last Update Posted (Actual)

October 20, 2026

Last Update Submitted That Met QC Criteria

October 16, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 26-46484
  • CA-0285698 (Other Grant/Funding Number: Geistlich)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe